Drug intelligence / Profile preview

Fem21

Development stage
Unknown
Lead developer
Lifestart Naturopathics
Modality
Small Molecules
Administration
Oral
01

Overview

Fem21 is a multi-ingredient women's health nutraceutical developed by Lifestart Naturopathics as a powdered oral supplement formulated from 21 herbs, botanicals, probiotics, and superfood ingredients. Based on the provided context, it is marketed to support hormonal balance and symptoms associated with PMS, dysmenorrhea, hormonal acne, irregular periods, endometriosis, menopausal symptoms, PCOS, and fertility concerns. Its proposed activity is nonspecific and systems-oriented rather than based on a single defined molecular target, with claimed support for endocrine function involving the ovaries, adrenal glands, and thyroid, as well as estrogen metabolism, progesterone production, liver function, and digestive health. Fem21 is therefore better characterized as a branded composite nutraceutical product rather than a pharmaceutical drug with a single active ingredient or well-validated target-specific mechanism.

Brand names
Fem21Fem-21Fem 21

Beyond the preview

Go deeper on Fem21.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fem21.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call